Health disparities in kidney disease - Emerging data from the human genome

New England Journal of Medicine

Volumn 369, Issue 23, 2013, Pages 2260-2261

  Williams, Winfred W ^a,c,d   Pollak, Martin R ^b,c,d  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

^d HARVARD UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APOL1 GENE; CHROMOSOME 22Q; DISEASE ASSOCIATION; EDITORIAL; END STAGE RENAL DISEASE; GENE; GENETIC VARIABILITY; GENOTYPE; HEALTH DISPARITY; HUMAN; HUMAN GENOME; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HYPERTENSION; KIDNEY DISEASE; PRIORITY JOURNAL; RACE DIFFERENCE; UNITED STATES;

EID: 84889255487     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMe1312797     Document Type: Editorial

References (11)

1. USRDS 2013 annual data report: atlas of chronic kidney disease and end-stage renal disease in the United States. Bethesda, MD: United States Renal Data System, 2013.
2. Lucas GM, Lau B, Atta MG, Fine DM, Keruly J, Moore RD. Chronic kidney disease incidence, and progression to end-stage renal disease, in HIV-infected individuals: a tale of two races. J Infect Dis 2008;197:1548-57.
3. Freedman BI, Spray BJ, Tuttle AB, Buckalew VM, Jr. The familial risk of end-stage renal disease in African Americans. Am J Kidney Dis 1993;21:387-93.
4. Kao WH, Klag MJ, Meoni LA, et al. MYH9 is associated with nondiabetic end-stage renal disease in African Americans. Nat Genet 2008;40:1185-92.
5. Kopp JB, Smith MW, Nelson GW, et al. MYH9 is a major-effect risk gene for focal segmental glomerulosclerosis. Nat Genet 2008;40:1175-84.
6. Genovese G, Friedman DJ, Ross MD, et al. Association of trypanolytic ApoL1 variants with kidney disease in African Americans. Science 2010;329:841-5.
7. Tzur S, Rosset S, Shemer R, et al. Missense mutations in the APOL1 gene are highly associated with end stage kidney disease risk previously attributed to the MYH9 gene. Hum Genet 2010;128:345-50.
8. Freedman BI, Kopp JB, Langefeld CD, et al. The apolipoprotein L1 (APOL1) gene and nondiabetic nephropathy in African Americans. J Am Soc Nephrol 2010;21:1422-6.
9. Parsa A, Kao WHL, Xie D, et al. APOL1 risk variants, race, and progression of chronic kidney disease. N Engl J Med 2013;369:2183-96.
10. Friedman DJ, Kozlitina J, Genovese G, Jog P, Pollak MR. Population-based risk assessment of APOL1 on renal disease. J Am Soc Nephrol 2011;22:2098-105.
11. Gill J, Dong J, Rose C, Johnston O, Landsberg D. The effect of race and income on living kidney donation in the United States. J Am Soc Nephrol 2013 August 29 (Epub ahead of print).